Results 211 to 220 of about 9,905,544 (245)

Interleukin-6: designing specific therapeutics for a complex cytokine

Nature reviews. Drug discovery, 2018
Christoph Garbers, Sylvia Heink, T. Korn, S. Rose-John   +3 more
semanticscholar   +1 more source

Interleukin 6

1998
Tadashi Matsuda, Tadamitsu Kishimoto
openaire   +2 more sources

[Interleukin-6/soluble interleukin-6 receptor].

Nihon rinsho. Japanese journal of clinical medicine, 2000
A, Yokoyama, K, Hiwada
openaire   +1 more source

Interleukin-6

2006
  +4 more sources

Interleukin-6

2016
openaire   +2 more sources

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Andrea Rubbert-Roth, César R Ramos-Remus, Rieke E Alten   +2 more
exaly  

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Lancet, The, 2013
Antoinette Moran, Linda A Dimeglio, Stephen E Gitelman   +2 more
exaly  

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes, Philip J Mease, Bruce W Kirkham   +2 more
exaly  

Role of interleukin-6 in cancer progression and therapeutic resistance

Tumor Biology, 2016
Neeraj Kumari, B. Dwarakanath, Asmita Das, A. Bhatt   +3 more
semanticscholar   +1 more source

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Lancet, The, 2017
B G Feagan, Julian Panes, Arthur Kaser
exaly